Infection Prevention Market
Market Insights on Infection Prevention covering sales outlook, demand forecast & up-to-date key trends
Infection Prevention Market by Product (Sterilization Equipment, Disinfectors, Consumables, Protective Apparel & Textiles, Infectious Waste Disposal), End User (Hospitals & Clinics, Pharmaceutical Companies, Clinical Laboratories & Life Sciences Industries) & Region - Forecast to 2021 - 2031
Infection Prevention Market Snapshot
[250 Pages] Infection Prevention Market is projected to witness positive growth, with the global revenue totaling US$ 37.4 Bn by 2021, according to Future Market Insights (FMI). Demand in the Infection Prevention Market is projected to rise at a CAGR of 4.2% during 2021 - 2031.
Rising cases of COVID-19, especially in emerging economies such as India, are expected to improve sales at an accelerated pace. As per FMI, the Infection Prevention Market is set to expand by 1.5x, surpassing US$ 56.4 Bn by 2031-end.
Let us know your requirement to get
100% FREE customization
Key Points Covered in Infection Prevention Market Study
- Infection Prevention Market estimates and forecast 2016-2031
- Key drivers and restraints impacting the Market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Infection Control Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Infection Prevention Market and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Infection Prevention Demand Outlook Compared to 2021-2031 Forecast
According to Future Market Insights (FMI), sales of Infection Prevention Market grew at a CAGR of 3.2% between 2016 and 2020. Impressive growth was registered during the FQ-20 due to the unprecedented outbreak of COVID-19.
As consumers are increasingly becoming conscious about their hygiene and personal health, greater demand for infection prevention products is registered. Sales prospects are expected to grow further as demand for advanced healthcare for geriatric population continues increasing.
Availability of a wide range of products based on heat sensitivity, type of chemical used as agents, type of medical instrument or material used for autoclaving, and sterilization methods such as radiation or liquid sterilization and the use of containers or wraps for treatment of infection are expected to create opportunities for the growth of the infection prevention market,
Based on aforementioned factors, Future Market Insights (FMI) has predicted the global Infection Prevention Market to grow at a CAGR of 4.2% over the forecast period 2021 -2031. Some of the leading companies who are actively participating in acquisitions, new product developments, and exclusive marketing agreements in order to expand their market presence will contribute significantly towards growth registered by the Infection Control Market.
How is the Adoption of Infection Prevention Products Within Hospitals Aiding Market Growth?
Rising cases of infectious diseases especially the ones associated with hospitals, diagnostic labs or any other health care facilities have been of major concern.
These include cases like surgical site infections, urinary tract infections, and pneumonia which night result in mortality in some cases. Infections in a hospital setting or hospital-acquired infection can spread through contamination of surface, materials, equipment, devices, linen, or even air droplets by direct or indirect contacts.
Acknowledging the growing burden of infectious diseases, government and private healthcare organizations are encouraging the adoption of infection control products across the globe.
According to the Centers for Disease Control and Prevention (CDC) report in 2015, 3% of the patients who were hospitalized had one or more hospital-acquired infections (HAI). Nearly 687,000 people were estimated to have acquired HAIs in acute care hospitals in U.S. Of those 72,000 patients having HAIs died during their hospitalization.
Increasing awareness about cleaning and disinfecting the environment, rising standards for effective cleaning, and the recent outbreak of coronavirus (COVID-19) are the factors providing lucrative growth opportunities for the Infection Prevention Market.
What are the Key Opportunities for Infection Control Market Players?
With increasing cases of infection worldwide, demand for solutions to address the cause of infection and provide the measures for reducing the risk of transmission is improving. Growing demand from healthcare sector for products such as sterilization equipment, disinfectors or consumables is expected to create remunerative revenues for key players.
Also, with surging demand for gloves, steriliums, disposables due to rise in number of surgical procedures is expected to provide opportunities for growth in Infection Prevention Market in the near future.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Infection Prevention Market Growth?
Long-term use of infection prevention products such as disinfectants and chemical agents across healthcare organizations may lead to unavoidable issues. These include deterioration of inanimate objects when in direct touch with a high concentration of chemicals due to its toxic nature.
Chronic exposure, sometimes, may lead to chronic diseases and health issues such as cancer, respiratory irritation, headaches, mutagenic changes, and breath shortening. These factors are likely to impede the Infection control Market growth.
International and government organizations have imposed stringent laws to avoid the adverse effects caused by over-exposure to these products. Organizations such as Occupational Safety and Health Administration (OSHA) and Food and Drug Administration (FDA) have implemented stringent regulations to monitor the proper disposal of waste generated by disinfectants production.
Additional forms and testing parameters have also been included to prove the sterility of medical devices, disinfectants, and sterilizing equipment. Health and environmental hazards associated with these chemicals will also pose a challenge for Infection Prevention Market players.
What is the Impact of the COVID-19 on Global Infection Prevention Market?
The COVID-19 pandemic had a positive impact on the infection prevention market. The rising number of COVID-19 infected cases across the world led to an increase in demand for infection prevention products such as sanitizers and surgical masks, not only in the healthcare sector but other sectors as well.
With the sudden outbreak of coronavirus, demand for infection control products witnessed a sudden spike. The outbreak resulted in a higher focus on research and development activities in the field of life science and the pharmaceutical sector. This rise in overall research activities resulted in demand for a higher supply of infection control products to keep the products, research equipment, and overall research environment safe and free from contamination.
Considering the mutant variants of COVID-19 and continuous efforts being undertaken by private and public organizations to curb the spread of the disease, demand for infection control products will continue rising over the coming years.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Infection Prevention Market - Country-wise Insights
Will the U.S. Remain a Key Infection Prevention Market?
As per FMI, North America is expected to dominate the global infection prevention market. With the U.S. contributing over 95% of the market share in 2021, the Infection Control Market is anticipated to exhibit healthy growth, surpassing US$ 17.11 Bn during the forecast period.
Soaring demand for industrial cleaners and disinfectants owing to higher awareness among healthcare service providers will improve the demand across the country. Increased spending on the healthcare infrastructure in the U.S. is expected to support the growth of infection prevention market.
Why is Germany Considered a Lucrative Infection Control Market Across Europe?
Germany and the U.K., collectively, are expected to account for over 40% of the Europe market in 2021. The increasing need to maintain and follow sanitary practices at a personal level and in healthcare facilities is driving the adoption of infection preventive products.
Implementation of infection prevention and control programs at the national and acute health care facilities across the country will provide ample growth opportunities for Infection Control market players.
How Big is the Opportunity in China?
The East Asia infection prevention market will exhibit healthy growth at 5.5% CAGR during the forecast period, with China vanguarding the sales in this region. In 2021, China is expected to account for nearly 47% sales in the East Asia Infection Control Market in terms of revenue.
With government constantly tracking population growth and newly diagnosed cases, demand for infection prevention products is expected to surge. Also, increasing the adoption of these products to combat any potential virus attack will improve the Infection Prevention market growth.
Additionally, key players in this region are focusing on product launches and are adopting inorganic growth strategies such as collaborations with local players to expand their service offerings, which is likely to augment Infection Control market growth in China.
What is scope of Infection Prevention Market in India?
India is expected to contribute over 50% of revenue in South Asia’s infection control market over the forecast period. Due to the increase in overall healthcare expenditure, increased access to the healthcare system, improved medical care facilities and healthcare services, infection prevention market is expected to bolster.
Infection Control Market - Category-wise Insights
Why is Demand for Disinfectors Increasing in Infection Prevention Market?
In terms of product type, the Infection Control Market is segmented into sterilization equipment, disinfectors, and consumables. As per Future Market Insights, the disinfectors segment is expected to lead the Infection Prevention Market growth.
It is estimated to gain nearly 30% of the total Infection Control market revenue share in the forecast period. Major contributing factors to this includes high utilization in the healthcare sectors to sanitize line, surface, instruments, and devices.
Why are Hospitals and Clinics Primary End-Users for Infection Prevention Market?
The hospitals and clinics segment is expected to be the most lucrative one as compared to other segments in terms of Infection Control Market share. The segment is poised to expand at a CAGR of over 3.4% during the forecast period.
A growing geriatric population, increasing hospitalization due to COIVD-19, and rising surgical procedures across the globe are the factors boosting the segment growth, driving sales of the infection control market.
Competitive Landscape
Manufacturers operating in infection prevention market are primarily aiming to carry out strategic expansion through merger and acquisitions, collaborations and product launches to consolidate growth in a competitive Infection Control Market.
For instance, in Feb 2019, Cantel Medical Corp acquired an Italian based company, Omnia S.p.A.to expand its portfolio with surgical consumable solutions.
In Dec 2020, Getinge AB launched Stainless Steel DPTE® Beta Containers which are designed to prevent spread of infections by efficient loading and unloading into sterile zones.
In April 2021, Pal International in partnership with Caswells Group focused on increasing its sales in the U.K.. for hygiene workwear.
Infection Prevention Market - Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Infection Prevention Market Analysis |
USD Million for Value. |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Infection Prevention Market - Key Segments Covered |
Product, End User and Region |
|
Infection Control Market - Key Companies Profiled |
|
|
Report Coverage |
Infection Prevention Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Infection Prevention Market by Category
By Product:
- Sterilization Equipment
- Low Temperature Equipment
- Ozone Sterilizers
- Hydrogen Peroxide Sterilizers
- Formaldehyde Sterilizers
- Ethylene Oxide Sterilizers
- Other Low-Temperature
- Heat Sterilization Equipment
- Moist Heat Sterilizers
- Dry Heat Sterilizers
- Radiation Sterilization Equipment
- Liquid Sterilization Equipment
- Low Temperature Equipment
- Disinfectors
- Washer Disinfectors
- Endoscope Repressors
- Flusher Disinfectors
- Surface Disinfectants
- Hand Sanitizers
- Consumables
- Sterilization Supplies
- Sterile Containers
- Sterilization Wrap
- Sterilization Indicators
- Sterilization Supplies
- Protective Apparel & Textiles
- Surgical Gloves
- Surgical Drapes
- Surgical Gowns
- Surgical Masks
- Infectious Waste Disposal
By End User:
- Hospitals & Clinics
- Pharmaceutical Companies
- Clinical Laboratories
- Medical Device Companies
- Life Sciences Industries
- Academic and Research Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa (MEA)
Frequently Asked Questions
The infection prevention market is predicted to grow at 4.2% CAGR through 2032.
China infection prevention market holds the highest growth potential.
The infection prevention market is expected to surpass US$ 58.8 Billion by 2032.
The infection prevention market size is anticipated to be over US$ 38.97 Billion in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Infection Control Market Coverage / Taxonomy
2.2. Infection Control Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Industry Outlook
4.1.2. COVID-19 Outbreak: Short-term Benefits for Disinfectant Chemical Companies
4.1.3. Steady Growth in Specialty Chemicals Industry to Boost Market Growth
4.2. Forecast Factors - Relevance & Impact
4.2.1. Incidence of Infection
4.2.2. Regulatory Imposition on Infection Prevention Products
4.2.3. Infection Prevention Products Pipeline Assessment
4.2.4. Incremental R&D by Product-Based Companies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Market Context
5.1. Product Adoption / Usage Analysis
5.2. Product USPs / Features
5.3. Strategic Promotional Strategies, By Key Manufacturers
5.4. Infection Prevention Products adoption, By Region
5.5. Key Regulations, By Region
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. COVID19 and Impact Analysis
6.4. 2020 Market Scenario
6.5. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Infection Prevention Products and Services Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Global Average Pricing Analysis Benchmark
8. Global Infection Prevention Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
8.1. Historical Infection Control Market Value (US$ Mn) Analysis, 2016-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Opportunity Analysis, 2021-2031
9. Global Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2016–2020
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2021-2031
9.3.1. Sterilization Equipment
9.3.1.1. Low Temperature Equipment
9.3.1.1.1. Ozone Sterilizers
9.3.1.1.2. Hydrogen Peroxide Sterilizers
9.3.1.1.3. Formaldehyde Sterilizers
9.3.1.1.4. Ethylene Oxide Sterilizers
9.3.1.1.5. Other Low-Temperature Sterilizers
9.3.1.2. Heat Sterilization Equipment
9.3.1.2.1. Moist Heat Sterilizers
9.3.1.2.2. Dry Heat Sterilizers
9.3.1.3. Radiation Sterilization Equipment
9.3.1.4. Liquid Sterilization Equipment
9.3.2. Disinfectors
9.3.2.1. Washer Disinfectors
9.3.2.2. Endoscope Repressors
9.3.2.3. Flusher Disinfectors
9.3.2.4. Surface Disinfectants
9.3.2.5. Hand Sanitizers
9.3.3. Consumables
9.3.3.1. Sterilization Supplies
9.3.3.1.1. Sterile Containers
9.3.3.1.2. Sterilization Wrap
9.3.3.1.3. Sterilization Indicators
9.3.3.2. Protective Apparel & Textiles
9.3.3.2.1. Surgical Gloves
9.3.3.2.2. Surgical Drapes
9.3.3.2.3. Surgical Gowns
9.3.3.2.4. Surgical Masks
9.3.3.3. Infectious Waste Disposal
9.4. Market Attractiveness Analysis By Product
10. Global Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2016–2020
10.3. Current and Future Infection Control Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
10.3.1. Hospitals & Clinics
10.3.2. Pharmaceutical Companies
10.3.3. Clinical Laboratories
10.3.4. Medical Device Companies
10.3.5. Life Sciences Industry
10.3.6. Academic and Research Centers
10.4. Market Attractiveness Analysis By End User
11. Global Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020
11.3. Current and Future Infection Control Market Size (UInfection ControlS$ Mn) Analysis and Forecast By Region, 2021-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints - Impact Analysis
13. Latin America Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis and Volume (Units) By Market Taxonomy, 2016–2020
13.3. Current and Future Market Size (US$ Mn) Analysis and Volume (Units) and Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Europe Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
14.3. Current and Future Infection Control Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. South Asia Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. East Asia Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. Oceania Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Infection Prevention Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Infection Control Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Infection Prevention Market Size (US$ Mn) and Volume (Units) Analysis and Forecast 2021 & 2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Infection Prevention Market Analysis
19.2.1. By Product
19.2.2. By End User
19.3. Canada Infection Prevention Market Analysis
19.3.1. By Product
19.3.2. By End User
19.4. Mexico Infection Prevention Market Analysis
19.4.1. By Product
19.4.2. By End User
19.5. Brazil Infection Prevention Market Analysis
19.5.1. By Product
19.5.2. By End User
19.6. U.K. Infection Prevention Market Analysis
19.6.1. By Product
19.6.2. By End User
19.7. Germany Infection Prevention Market Analysis
19.7.1. By Product
19.7.2. By End User
19.8. France Infection Prevention Market Analysis
19.8.1. By Product
19.8.2. By End User
19.9. Italy Infection Prevention Market Analysis
19.9.1. By Product
19.9.2. By End User
19.10. Spain Infection Prevention Market Analysis
19.10.1. By Product
19.10.2. By End User
19.11. BENELUX Infection Prevention Market Analysis
19.11.1. By Product
19.11.2. By End User
19.12. Russia Infection Prevention Market Analysis
19.12.1. By Product
19.12.2. By End User
19.13. China Infection Prevention Market Analysis
19.13.1. By Product
19.13.2. By End User
19.14. Japan Infection Prevention Market Analysis
19.14.1. By Product
19.14.2. By End User
19.15. South Korea Infection Prevention Market Analysis
19.15.1. By Product
19.15.2. By End User
19.16. India Infection Prevention Market Analysis
19.16.1. By Product
19.16.2. By End User
19.17. ASEAN Infection Prevention Market Analysis
19.17.1. By Product
19.17.2. By End User
19.18. Australia Infection Prevention Market Analysis
19.18.1. By Product
19.18.2. By End User
19.19. New Zealand Infection Prevention Market Analysis
19.19.1. By Product
19.19.2. By End User
19.20. GCC Countries Infection Prevention Market Analysis
19.20.1. By Product
19.20.2. By End User
19.21. Turkey Infection Prevention Market Analysis
19.21.1. By Product
19.21.2. By End User
19.22. South Africa Infection Prevention Market Analysis
19.22.1. By Product
19.22.2. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Product Foot print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Cantel Medical
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Getinge
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Steris
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Advanced Sterilization Products
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Sotera Health
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. 3M
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Ecolab
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Halyard Health
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Matachana
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Belimed
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. Pal International
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Reckitt Benckiser Group Plc.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Product Strategy
21.3.12.5.3. Channel Strategy
21.3.13. Metrex Research
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.13.5.1. Marketing Strategy
21.3.13.5.2. Product Strategy
21.3.13.5.3. Channel Strategy
21.3.14. Terumo Corporation
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
21.3.14.4. Sales Footprint
21.3.14.5. Strategy Overview
21.3.14.5.1. Marketing Strategy
21.3.14.5.2. Product Strategy
21.3.14.5.3. Channel Strategy
21.3.15. Ahlstrom Corporation
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
21.3.15.4. Sales Footprint
21.3.15.5. Strategy Overview
21.3.15.5.1. Marketing Strategy
21.3.15.5.2. Product Strategy
21.3.15.5.3. Channel Strategy
21.3.16. Ansell Limited
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Profitability by Market Segments (Product/Channel/Region)
21.3.16.4. Sales Footprint
21.3.16.5. Strategy Overview
21.3.16.5.1. Marketing Strategy
21.3.16.5.2. Product Strategy
21.3.16.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1A: Global Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 1B: Global Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 1C: Global Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 2: Global Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 03: Global Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Region
Table 4A: North America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 4B: North America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 4C: North America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 5A: North America Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 5B: North America Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 5C: North America Infection Prevention Market Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 06: North America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 07: North America Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 8A: Latin America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 8B: Latin America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 8C: Latin America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 9A: Latin America Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 9B: Latin America Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 9C: Latin America Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 10: Latin America Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 11: Latin America Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11A: Europe Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 11B: Europe Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 11C: Europe Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 12A: Europe Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 12B: Europe Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 12C: Europe Infection Prevention Market Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 13: Europe Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 14: Europe Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 15A: South Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 15B: South Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 15C: South Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 16A: South Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 16B: South Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 16C: South Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 17: South Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 18: South Asia Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 19A: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 19B: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 19C: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 20A: East Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 20B: East Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 20C: East Asia Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 21: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 22: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 23A: Oceania Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 23B: Oceania Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 23C: East Asia Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 24A: Oceania Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 23B: Oceania Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 23C: Oceania Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 25: Oceania Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 26: Oceania Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 27A: MEA Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product Ty7
Table 27B: MEA Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 27C: MEA Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 28A: MEA Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 28B: MEA Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 28C: MEA Infection Prevention Market Volume Analysis 2016–2020 and Forecast 2021-2031, By Product
Table 29: MEA Infection Prevention Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021-2031, By End User
Table 30: MEA Infection Prevention Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Ozone Sterilizers (per unit) Pricing Analysis (US$), By Region, 2020
Figure 02: Hydrogen Peroxide Sterilizers (per unit) Pricing Analysis By Region, 2029
Figure 03: Formaldehyde Sterilizers (per unit) Pricing Analysis (US$), By Region, 2018,
Figure 04: Ethylene Oxide Sterilizers (per unit) Pricing Analysis (US$), By Region, 2029
Figure 05: Moist Heat Sterilizers (per unit) Pricing Analysis (US$), By Region, 2018
Figure 06: Dry Heat Sterilizers (pack of 10) Pricing Analysis (US$), By Region, 2029
Figure 07: Radiation Sterilizers (per unit) Pricing Analysis (US$), By Region, 2018
Figure 08: Liquid Sterilization Equipment (per unit) Pricing Analysis (US$), By Region, 2029
Figure 09: Washer Disinfectors (per unit) Pricing Analysis (US$), By Region, 2018
Figure 10: Flusher Disinfectors (per unit) Pricing Analysis (US$), By Region, 2029
Figure 11: Endoscope Reprocessors (per unit) Pricing Analysis (US$), By Region, 2018
Figure 12: Surface Disinfectants (per liter) Pricing Analysis (US$), By Region, 2029
Figure 13: Hand Sanitizers (per liter) Pricing Analysis (US$), By Region, 2018
Figure 14: Sterilization Indicators (single unit) Pricing Analysis (US$), By Region, 2029
Figure 16: Surgical Gowns (Per unit) Pricing Analysis (US$), By Region, 2018
Figure 17: Surgical Drapes (per unit) Pricing Analysis (US$), By Region, 2029
Figure 18: Surgical Gloves (Pack of 10) Pricing Analysis (US$), By Region, 2018
Figure 19: Surgical Masks (pack of 3) Pricing Analysis (US$), By Region, 2029
Figure 20: Sterile Containers (pack of 100 containers) Pricing Analysis (US$), By Region, 2018
Figure 21: Sterilization Wrap (Case of 1000) (12" x 12") Pricing Analysis (US$), By Region, 2029
Figure 22: Infectious Waste Disposal (per unit) Pricing Analysis (US$), By Region, 2018
Figure 23: Global Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 24: Global Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 25: Global Infection Prevention Market Absolute $ Opportunity, 2021-2031
Figure 26: Global Infection Prevention Market Share, By Product, 2021 & 2031
Figure 27: Global Infection Prevention Market Y-o-Y Growth Projections By Product, 2021 – 2031
Figure 28: Global Infection Prevention Market Attractiveness Analysis, By Product
Figure 29: Global Infection Prevention Market Share, By End User, 2021 & 2031
Figure 30: Global Infection Prevention Market Y-o-Y Growth Projections By End User, 2021 – 2031
Figure 31: Global Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 32: Global Infection Prevention Market Share, By Region,
Figure 33: Global Infection Prevention Market Attractiveness Analysis By Region, 2021-2031
Figure 34: Global Infection Prevention Market Attractiveness Analysis By Region, 2021-2031
Figure 35: North America Infection Prevention Market Share, By Product, 2021 (E)
Figure 37: North America Herbal Medicinal Products Market Value Share By Country (2021)
Figure 36: North America Infection Prevention Market Share, By End Users, 2021 (E)
Figure 38: North America Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 39: North America Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 40: North America Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 41: North America Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 42: North America Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 43: Latin America Infection Prevention Market Share, By Product, 2021 (E)
Figure 45: Latin America Infection Prevention Market Value Share By Country (2021)
Figure 44: Latin America Infection Prevention Market Share, By End Users, 2021 (E)
Figure 46: Latin America Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 47: Latin America Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 48: Latin America Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 49: Latin America Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 50: Latin America Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 51: Europe Infection Prevention Market Share, By Product, 2021 (E)
Figure 53: Europe Herbal Medicinal Products Market Value Share By Country (2021)
Figure 52: Europe Infection Prevention Market Share, By End Users, 2021 (E)
Figure 54: Europe Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 55: Europe Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 56: Europe Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 57: Europe Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 58: Europe Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 59: South Asia Infection Prevention Market Share, By Product, 2021 (E)
Figure 61: South Asia Infection prevention Market Value Share by Country (2021)
Figure 60: South Asia Infection Prevention Market Share, By End Users, 2021 (E)
Figure 62: South Asia Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 63: South Asia Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 64: South Asia Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 65: South Asia Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 66: South Asia Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 67: East Asia Infection Prevention Market Share, By Product, 2021 (E)
Figure 69: East Asia Herbal Medicinal Products Market Value Share By Country (2021)
Figure 68: East Asia Infection Prevention Market Share, By End Users, 2021 (E)
Figure 70: East Asia Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 71: East Asia Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 72: East Asia Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 73: East Asia Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 74: East Asia Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 75: Oceania Infection Prevention Market Share, By Product, 2021 (E)
Figure 77: Oceania Herbal Medicinal Products Market Value Share By Country (2021)
Figure 76: Oceania Infection Prevention Market Share, By End Users, 2021 (E)
Figure 78: Oceania Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 79: Oceania Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 80: Oceania Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 81: Oceania Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 82: Oceania Infection Prevention Market Attractiveness Analysis By End User 2021-2031
Figure 83: MEA Infection Prevention Market Share, By Product, 2021 (E)
Figure 85: MEA Herbal Medicinal Products Market Value Share By Country (2021)
Figure 84: MEA Infection Prevention Market Share, By End Users, 2021 (E)
Figure 86: MEA Infection Prevention Market Value Analysis (US$ Mn), 2016-2020
Figure 87: MEA Infection Prevention Market Value Analysis (US$ Mn), 2021-2031
Figure 88: MEA Infection Prevention Market Attractiveness Analysis By Country, 2021-2031
Figure 89: MEA Infection Prevention Market Attractiveness Analysis By Product, 2021-2031
Figure 90: MEA Infection Prevention Market Attractiveness Analysis By End User, 2021-2031
Figure 91: Global Vs. U.S. Growth Comparison
Figure 92: U.S. Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 93: U.S. Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 94: U.S. Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 95: Global Vs. U.S. Growth Comparison
Figure 96: Canada Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 97: Canada Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 98: Canada Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 99: Global Vs. Brazil Growth Comparison
Figure 100: Brazil Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Brazil Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 102: Brazil Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 103: Global Vs. Mexico Growth Comparison
Figure 104: Mexico Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 105: Mexico Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 106: Mexico Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 107: Global Vs. Argentina Growth Comparison
Figure 108: Argentina Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 109: Argentina Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 110: Argentina Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 111: Global Vs. U.K. Growth Comparison
Figure 112: U.K. Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: U.K. Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 114: U.K. Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 115: Global Vs. Germany Growth Comparison
Figure 116: Germany Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 117: Germany Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 118: Germany Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 119: Global Vs. France Growth Comparison
Figure 120: France Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 121: France Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 122: France Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 119: Global Vs. Italy Growth Comparison
Figure 124: Italy Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: Italy Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 126: Italy Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 127: Global Vs. Spain Growth Comparison
Figure 128: Spain Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 129: Spain Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 130: Spain Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 131: Global Vs. BENELUX Growth Comparison
Figure 132: BENELUX Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 133: BENELUX Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 134: BENELUX Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 135: Global Vs. Russia Growth Comparison
Figure 136: Russia Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 137: Russia Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 138: Russia Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 139: Global Vs. China Growth Comparison
Figure 140: China Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 141: China Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 142: China Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 143: Global Vs. Japan Growth Comparison
Figure 144: Japan Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 145: Japan Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 146: Japan Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 147: Global Vs. South Korea Growth Comparison
Figure 148: South Korea Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 149: South Korea Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 150: South Korea Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 147: Global Vs. India Growth Comparison
Figure 152: India Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 153: India Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 154: India Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 155: Global Vs. Indonesia Growth Comparison
Figure 156: Indonesia Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 157: Indonesia Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 158: Indonesia Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 159: Global Vs. Thailand Growth Comparison
Figure 160: Thailand Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 161: Thailand Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 162: Thailand Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 163: Global Vs. Malaysia Growth Comparison
Figure 164: Malaysia Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 165: Malaysia Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 166: Malaysia Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 167: Global Vs. Australia Growth Comparison
Figure 168: Australia Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 169: Australia Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 170: Australia Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 171: Global Vs. New Zealand Growth Comparison
Figure 172: New Zealand Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 173: New Zealand Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 174: New Zealand Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 175: Global Vs. South Africa Growth Comparison
Figure 176: South Africa Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 177: South Africa Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 178: South Africa Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 179: Global Vs. Turkey Growth Comparison
Figure 180: Turkey Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 181: Turkey Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 182: Turkey Infection Prevention Market Value Share, By End User, 2021 & 2031
Figure 179: Global Vs. GCC Countries Growth Comparison
Figure 184: GCC Countries Infection Prevention Market Value Analysis (US$ Mn), 2021 & 2031
Figure 185: GCC Countries Infection Prevention Market Value Share, By Product, 2021 & 2031
Figure 186: GCC Countries Infection Prevention Market Value Share, By End User, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
